← Back to Search

Behavioural Intervention

AeviceMD for Pediatric Asthma (APAM Trial)

N/A
Waitlist Available
Led By Irina Dralyuk, MD
Research Sponsored by Irina Dralyuk
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to use a wearable device called AeviceMD to monitor the breathing of pediatric asthma patients at home. By using this device, patients can better manage their asthma, and doctors can adjust treatments

Who is the study for?
This trial is for children with asthma. Participants should be currently managing their asthma and looking to improve control over the disease at home. They must be willing to use AeviceMD, a wearable monitor, as part of their treatment plan.
What is being tested?
The study tests AeviceMD, a wearable device designed to monitor respiratory health in kids with asthma. It aims to help patients manage their condition better at home and provide doctors with data for optimizing treatment.
What are the potential side effects?
Since AeviceMD is a monitoring device, it's not expected to have direct side effects like medications do. However, there may be discomfort or skin irritation from wearing the device.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To evaluate the effectiveness of implementing home monitoring technology for asthma patients in delivering care to patients and in extension determine, if Aevice Medical Device can improve home management of Asthma for pediatrics patients.
Secondary study objectives
To determine if the AeviceMD is effective as a remote auscultation tool for the facilitation of teleconsultations.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: AeviceMDExperimental Treatment1 Intervention
This is a single site, single arm, open label medical device (AeviceMD) pilot where only intervention groups will be recruited.

Find a Location

Who is running the clinical trial?

Irina DralyukLead Sponsor
AEvice Health Pte LtdOTHER
1 Previous Clinical Trials
35 Total Patients Enrolled
Irina Dralyuk, MDPrincipal InvestigatorCedars-Sinai Medical Center
~4 spots leftby Feb 2025